KKR has sweetened its offer for Spectris to £41.75 per share, valuing the London-listed precision instrumentation maker’s equity at around £4.2 billion (about $5.6 billion) after a string of failed attempts.
The latest shot in the bidding war follows Advent International‘s revised £41 per share offer last Friday; the Spectris board has now rejected that proposal.
KKR‘s increased offer, which includes £41.47 per share in cash as well as an interim dividend of 28 pence per share, represents a 104.9% premium over Spectris’ closing price of £20.38 on June 6, the last trading day before the UK-based company entered takeover talks. It also marks a 1.8% increase on Advent’s latest bid and is 4.4% higher than KKR’s original offer announced in early July.
This is the fourth time the Spectris board has switched its backing.
Spectris would be KKR’s largest UK deal this year. The PE giant has already lost several high-profile UK deals this year.
In May, KKR withdrew from the bidding for analytics provider GlobalData. A month later, its consortium missed out on healthcare real estate investment trust Assura after the board backed a rival offer from Primary Health Properties.
In the private markets, KKR last month decided not to invest £4 billion in Thames Water after conducting more than two months of due diligence on the embattled UK utility.
VWPics/Universal Images Group via Getty Images
Learn about our editorial standards.